Active, Not Recruiting A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors NCT03899792 Conditions Adenocarcinoma, Adenocarcinoma, Papillary, Breast Diseases, +52 more Locations Childrens Hospital of Los Angeles — Los Angeles, California, United States The Children's Hospital for Cancer and Blood Disorders — Aurora, Colorado, United States Nemours Children's Health — Orlando, Florida, United States Dana-Farber Cancer Institute — Boston, Massachusetts, United States View all 26 locations View more locations Show fewer locations Loading locations... View Trial Details
